Thomas Kristensen (T K Kristensen, T Kristensen)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 5

Top Topics

Dna Methylation

Bioinformatics Analysis

Pulmonary Embolism

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Kristensen, Hanne Vestergaard, Carsten Bindslev-Jensen, Michael Boe Møller, Sigurd Broesby-Olsen, null null
Clinical validation of a new commercial highly sensitive KIT D816V mutation analysis in mastocytosis. Allergy 75 (6) (2020)
Thomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, Carsten Bindslev-Jensen, Charlotte Gotthard Mortz, Henrik Fomsgaard Kjaer, Michael Boe Møller, null null
Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-blood. Leukemia & lymphoma 60 (1) (2018)
A Ruiz Oropeza, C Bindslev-Jensen, Sigurd Broesby-Olsen, Thomas Kristensen, M B Møller, H Vestergaard, H F Kjaer, S Halken, A Lassen, Charlotte Gotthard Mortz
Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis. Allergy 72 (12) (2017)
Sigurd Broesby-Olsen, H Vestergaard, Charlotte Gotthard Mortz, B Jensen, T Havelund, A P Hermann, F Siebenhaar, M B Møller, Thomas Kristensen, C Bindslev-Jensen, null null
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations. Allergy 73 (1) (2017)
Thomas Kristensen, H Vestergaard, C Bindslev-Jensen, Charlotte Gotthard Mortz, H F Kjaer, M Ollert, M B Møller, S Broesby-Olsen, null null
Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis. Allergy 72 (11) (2017)